Publication:
Impact of introducing sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes without complications

dc.contributor.coauthorMehta, R.
dc.contributor.coauthorBahia, L.
dc.contributor.coauthorSaif, A.
dc.contributor.coauthorMusso, C.
dc.contributor.coauthorSubramaniam, S.
dc.contributor.coauthorGabriel, Z.
dc.contributor.coauthorGoncalves, S.
dc.contributor.coauthorSolorzano, J.
dc.contributor.coauthorVasnawala, H.
dc.contributor.coauthorSchabert, V.
dc.contributor.coauthorMihajlovic, J.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorDeyneli, Oğuzhan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-12-29T09:37:04Z
dc.date.issued2023
dc.description.indexedbyWOS
dc.description.issueSupplement 1
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume197
dc.identifier.doi10.1016/j.diabres.2023.110480
dc.identifier.eissn1872-8227
dc.identifier.issn0168-8227
dc.identifier.quartileQ1
dc.identifier.urihttps://doi.org/10.1016/j.diabres.2023.110480
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22258
dc.identifier.wos1032097300217
dc.keywordsMedicine
dc.language.isoeng
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofDiabetes Research and Clinical Practice
dc.subjectEndocrinology and metabolism
dc.titleImpact of introducing sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes without complications
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorDeyneli, Oğuzhan
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files